Monte Rosa Therapeutics, Inc. (GLUE) reported Q1 Revenue

Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) reported Q1 Revenue for the quarter came in at $84.93 million versus the consensus estimate of $4.91 million.

For earnings history and earnings-related data on Monte Rosa Therapeutics, Inc. (GLUE) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS says bull market has further to run
• AMD (AMD) call put ratio 1 call to 1.8 put with a focus on August 28 weekly 305 puts